AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$AORT

ARTIVION, INC.

Price · $AORTvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $AORT in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $AORT in the last 30 days.

Top stories · $AORTMore →
MAY 20·Stock TitanMed

Artivion (AORT) director receives 7,850-share stock award, now holds 56,938

Artivion (AORT) Director Marna P. Borgstrom has received an equity compensation grant of 7,850 shares of Common Stock at a stated price of $0.00 per share, as reported in a Form 4 SEC filing. This award, part of the company's Equity and Cash Incentive Plan, increases her direct holdings to 56,938 shares. The RSA grant is scheduled to vest on May 14, 2027, aligning director compensation with the company's long-term performance.

MAR 16·MarketBeat

Juniper Investment Company LLC Sells 760,257 Shares of Artivion, Inc. $AORT

Juniper Investment Company LLC significantly reduced its stake in Artivion, Inc. (NYSE:AORT) by 36.3%, selling 760,257 shares and now owning 1,333,692 shares valued at $56.47 million. Despite insider selling and a high P/E ratio, other institutional investors like Vanguard and Two Sigma increased their holdings, and analysts maintain a "Moderate Buy" rating with an average target price of $50.47. Artivion recently exceeded earnings and revenue expectations.

DEC 17·Investing.com Canada

Artivion Inc stock hits all-time high at 48.06 USD By Investing.com

Artivion Inc.'s stock (AORT) reached an all-time high of $48.06, driven by strong investor confidence and impressive financial performance, including a 58.86% one-year return and a recent beat on Q3 2025 earnings. Analysts maintain optimistic outlooks with raised price targets, reflecting confidence in the company's future prospects and upcoming product launches.

News on $AORT